Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyidithio) ethyl] mitomycin C (BMY-25067) William T. BradnerWilliam C. RoseAlexander P. Florczyk Preclinical Studies Pages: S1 - S7
Schedule dependent potentiation of antitumor drug effects by α-difluoromethylornithine in human gastric carcinoma cells in vitro Sam C. BarrancoCourtney M. Townsend Jr.Pamella J. Ford Preclinical Studies Pages: S9 - S18
Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines A. HarstrickJ. CasperH. Poliwoda Preclinical Studies Pages: S19 - S24
Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30 William C. RoseGeorge A. BaslerAnna Maria Casazza Preclinical Studies Pages: S25 - S32
Phase I study of tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide, NSC 286193) J. A. MarounD. J. Stewart Clinical Studies Pages: S33 - S39
Phase I trial of a 5-day course of carbetimer Steven M. GrunbergElizabeth EhlerMalcolm S. Mitchell Clinical Studies Pages: S41 - S49
A phase I and pharmacokinetic study of intravenous vinzolidine Charles W. TaylorSydney E. SalmonDavid S. Alberts Clinical Studies Pages: S51 - S57
Combination high-dose etoposide and vincristine infusion Don V. Jackson Jr.Julia M. CruzAllen R. Chauvenet Clinical Studies Pages: S59 - S64
Phase II trial of fludarabine phosphate (F-ara-AMP) in patients with advanced head and neck cancer A. MittelmanS. SavonaZ. Arlin Clinical Studies Pages: S65 - S67
Evaluation of menogaril in renal cell carcinoma Ronald L. StephensPhyllis GoodmanRonald B. Natale Clinical Studies Pages: S69 - S71
Phase II study of 4-demethoxydaunorubicin in previously untreated extensive disease non-small cell lung cancer Theera UmsawasdiTyrone B. FelderRobert A. Newman Clinical Studies Pages: S73 - S78
Phase II trial of methylglyoxal bis-guanylhydrazone (MGBG) in refractory small cell lung cancer Michael S. SimonJohn EckenrodeRonald B. Natale Clinical Studies Pages: S79 - S81
A phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma Mark B. EdelsteinJohn J. CrowleyJames S. Ungerleider Clinical Studies Pages: S83 - S86
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma William A. Knight IIIPhyllis GoodmanLaurence H. Baker Clinical Studies Pages: S87 - S89
A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy Donald L. TrumpJohn C. MarshSteven E. Vogl Clinical Studies Pages: S91 - S94
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma S. B. KayeM. ClavelF. Cavalli Clinical Studies Pages: S95 - S99